Propofol Inhibits Proliferation and Augments the Anti-Tumor Effect of Doxorubicin and Paclitaxel Partly Through Promoting Ferroptosis in Triple-Negative Breast Cancer Cells

BACKGROUND: Triple-negative breast cancer (TNBC) is relatively common in women and is associated with a poor prognosis after surgery and adjuvant chemotherapy. Currently, the mechanism underlying the relationship between propofol and breast cancer is controversial and limited to cell apoptosis. More...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chen, Liu, Pan, Pei, Lijian, Zhao, Mengyun, Huang, Yuguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996258/
https://www.ncbi.nlm.nih.gov/pubmed/35419287
http://dx.doi.org/10.3389/fonc.2022.837974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996258/
https://www.ncbi.nlm.nih.gov/pubmed/35419287
http://dx.doi.org/10.3389/fonc.2022.837974

Ejemplares similares